Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q15910: Variant p.Pro132Ser

Histone-lysine N-methyltransferase EZH2
Gene: EZH2
Feedback?
Variant information Variant position: help 132 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Proline (P) to Serine (S) at position 132 (P132S, p.Pro132Ser). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and hydrophobic (P) to small size and polar (S) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In WVS; decreased histone methyltransferase activity. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 132 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 746 The length of the canonical sequence.
Location on the sequence: help SWSPLQQNFMVEDETVLHNI P YMGDEVLDQDGTFIEELIKN The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         SWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKN

Mouse                         SWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKN

Xenopus tropicalis            SWSPLQQNFMVEDETVLHNIPYMGDEVLDQDGTFIEELIKN

Zebrafish                     SWSPLQQNFMVEDETVLHNIPYMGDEILDQDGTFIEELIKN
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 746 Histone-lysine N-methyltransferase EZH2
Region 1 – 340 Interaction with DNMT1, DNMT3A and DNMT3B



Literature citations
Mutations in EZH2 cause Weaver syndrome.
Gibson W.T.; Hood R.L.; Zhan S.H.; Bulman D.E.; Fejes A.P.; Moore R.; Mungall A.J.; Eydoux P.; Babul-Hirji R.; An J.; Marra M.A.; Chitayat D.; Boycott K.M.; Weaver D.D.; Jones S.J.;
Am. J. Hum. Genet. 90:110-118(2012)
Cited for: VARIANTS WVS SER-132; TYR-153 DEL AND TYR-689; Weaver Syndrome-Associated EZH2 Protein Variants Show Impaired Histone Methyltransferase Function In Vitro.
Cohen A.S.; Yap D.B.; Lewis M.E.; Chijiwa C.; Ramos-Arroyo M.A.; Tkachenko N.; Milano V.; Fradin M.; McKinnon M.L.; Townsend K.N.; Xu J.; Van Allen M.I.; Ross C.J.; Dobyns W.B.; Weaver D.D.; Gibson W.T.;
Hum. Mutat. 37:301-307(2016)
Cited for: VARIANTS WVS CYS-133 AND CYS-679; CHARACTERIZATION OF VARIANTS WVS SER-132; CYS-133; TYR-153 DEL; CYS-679 AND TYR-689; VARIANT HIS-185; CHARACTERIZATION OF VARIANT HIS-185; MUTAGENESIS OF PHE-667;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.